In summary, EZH2 suppressed the expression of miR‐4448, which directly inhibited the girdin gene, thereby preventing EZH2‐induced EMT and tumorigenesis through the Akt/AMPK pathway in SCLC. The gene discussed is AKT1; the disease is small cell lung carcinoma.